About the Company : Sumar Biotech LLP, registered in January 2018, is a startup approved by the Gujarat State Biotechnology Mission
Novo claims that Hims is using deceptive marketing to widely sell compounded semaglutide to its users, despite a recent crackdown from federal regulators
"GLP-1 medications are truly a breakthrough in weight management, but they can also create significant nutrient gaps in things like vitamin B12, vitamin D, iron and calcium," says Matthew Taylor, Sr
Affordable Everyday
Among people who use the drugs for diabetes and obesity, evidence suggests the drugs reduce the risks of kidney disease progression, heart attack, death from heart disease, death from COVID-19, and death from all causes by 15% to 35%